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2Preamble
In College I was told that 
Biology was too complicated
to use Math.
I have learned by now that 
Biology is too complicated
not to use Math.
3Overview
Metabolic Engineering
Challenges and Need for Models
Canonical Modeling; Biochemical Systems Theory
Advantages, Examples
Issues of Optimization 
IBSI: An Overview
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http://www.metabolicengineering.gov/
Metabolic Engineering is a new approach to understanding 
and using metabolic processes. As the name implies, ME is the 
targeted and purposeful alteration of metabolic pathways found 
in an organism in order to better understand and use cellular 
pathways for chemical transformation, energy transduction, 
and supramolecular assembly. 
Metabolic Engineering
5In the past:
Strain and productivity improvement through random
mutagenesis and selection (strain and medium); maybe 
adaptive evolution
Q:  Isn’t there a more rational way of doing this?
Now and Future:
Develop mathematical models of organisms, manipulate
models, implement successful implementation in actual
organisms
Metabolic Engineering
6Currie started in 1915
Our Task:
Compute how to 
reroute flux in an
optimal fashion;
e.g., maximize
citric acid output
Big challenge:
Complexity of 
biological systems
Example:
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7Large numbers of components
Large number of processes
Processes are nonlinear
Quantitative changes in parameters cause
qualitative changes in response
Features of
Organizational Complex Systems
8100 billion neuronal components in human brain
5 octillion atoms in human body:
5,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000
100s of trillions of interconnections between neurons
Miller (1956):  Human brain can manage 7+2 items at once
Large Numbers of 
Components and Processes
6,000 genes in S. cerevisiae
Thousands of proteins in E. coli
9Biological Systems are Scary !
10
S   ystems Analysis to the Rescue!
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Generic Modeling of Pathway Systems
Model
Understanding
Extrapolation
Manipulation
Optimization
Model 
Structure
Literature, KEGG, de novo Experiments
“Local” Data
Literature, Brenda,
de novo Experiments
(Enzyme Kinetics)
Local Processes 
“Global” Data
Internet, 
de novo Experiments
(Microarrays, 
Proteomics,
Mass Spec, NMR, 
Time Series)
Diagnostics, Testing
Validation
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Generic Modeling of Pathway Systems
Model
Understanding
Extrapolation
Manipulation
Optimization
Model 
Structure
Literature, KEGG, de novo Experiments
“Local” Data
Literature, Brenda,
de novo Experiments
(Enzyme Kinetics)
Local Processes 
“Global” Data
Internet, 
de novo Experiments
(Microarrays, 
Proteomics,
Mass Spec, NMR, 
Time Series)
Diagnostics, Testing
Validation
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Change in substrate concentrations (S) is function of fluxes
(V) and stoichiometric matrix N:     dS/dt = N·V = 0
Flux-Balance Analysis (Bernhard Palsson group):
Reduce solution space with physico-chemical constraints
Stoichiometric Systems
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Advantages:
No kinetic details needed, just topology and fluxes 
Linear system (no real size limitation)
Straightforward optimization
Steady-state solution space given by kernel
Limitations:
Kinetic information cannot be used
No nonlinearities
No true regulatory signals possible
Optimal strategies of flux alteration 
affected by signals
Stoichiometric Systems
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A nonlinear formalism that:
captures the essence of biological systems
accounts for physiological and pathological
processes, regulation, signal transduction…
yields insight
lends itself to (manageable) analysis
lends itself to (manageable) simulation
lends itself to optimization
is computationally efficient
Wanted
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Needs to be Based on Integrated Systems Analysis:
Each component of the system may potentially depend
on all other components and outside factors.
To “understand” the system, we need to know how 
every component changes over time.
Dynamic changes in a system component are driven 
by inputs and outputs.
Toward a Nonlinear Modeling Framework
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Formulation of a
Dynamical Systems Model
complicated
Big Problem:  Where do we get functions from?
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Sources of Functions for 
Complex Systems Models 
Physics:  Functions come from theory
Biology: No theory available 
Solution 1: Educated guesses: growth functions
Solution 2: “Partial” theory:  Enzyme kinetics
Solution 3: Generic approximation
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from Schultz (1994)
A+B P+Q
Why not Use “True” Functions?
20
Why not Use Linear Functions?
sin(t)
0 30 60
0
2
4
time
Example: Heartbeat modeled as stable limit cycle
System of linear 
differential equations
vdP(t)
0 30 60
0
2
4
time
System of non-linear 
differential equations
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Formulation of a Model
for Complex Systems
Challenge:
Linear approximation unsuited
Infinitely many nonlinear functions
Solution with Potential:
Savageau (1969): Approximate Vi+ and Vi– in a 
logarithmic coordinate system, using Taylor theory.
Result: Canonical Modeling; Biochemical Systems Theory.
−+ −== iiii VVdt
dX
X&
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Important:
Each term contains and only those variables that have a 
direct effect; others have exponents of 0 and drop out.
Automated model design possible!
Result: S-system
Each term is represented as a product of power-functions.
α’s and β’s are rate constants, g’s and h’s kinetic orders.
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S-system Form:
Xi
Vi1+ Vi1–
Vi,p+ Vi,q–
−+ ∑∑ −== ijijii VVdtdXX&
Alternative Formulations
within BST
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S-system Form:
Xi
Vi1+ Vi1–
Vi,p+ Vi,q–
−+ ∑∑ −== ijijii VVdtdXX&
Generalized Mass Action Form:
∑ ∏±= ijkfjiki XX γ&
Alternative Formulations
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Sphingolipid pathway
(purely metabolic)
1. ~25 metabolites
2. ~ 30 enzyme steps
3. Many parameters
4. Values from literature; 
some in vivo experiments
Doable Size
Alvarez, Sims , Hannun, Voit
JTB, 2004; Nature, 2005
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Pathways: purines, glycolysis, citric acid, TCA, red blood cell,
trehalose, sphingolipids, dopamine, lignin synthesis, ...
Genes: circuitry, regulation,…
Genome:  explain expression patterns upon stimulus
Metabolic engineering, maximization of yield,…
Growth, immunology, pharmaceutical science, forestry, ...
Math:  recasting, function classification, bifurcation analysis,...
Statistics:  S-system representation, S-distribution, trends;
applied to seafood safety, marine mammals, health economics
Applications of BST
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Define Yi = log(Xi): 
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S-system highly nonlinear, but steady-state equations linear.
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Steady-State Equations Linear
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Optimization under steady-state (batch) conditions becomes 
Linear Program
even though (nonlinear) kinetics is taken into account:
maximize log(flux)    [or log(variable)]
subject to:
Steady-state conditions in log(variables)
Constraints on log(variables)
Constraints on log(fluxes)
Pathway Optimization with S-systems
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Great Advantage: 
Methods of Operations Research applicable
•  very well understood 
•  applicable for  over 1,000 simultaneous variables
•  robust and efficient
•  incomparably faster than nonlinear methods
Torres, Alvarez, Voit, …: Applications (e.g., citric acid, 
ethanol, glycerol, L-carnitine)
Pathway Optimization (cont’d)
Hatzimanikatis, Bailey, Floudas, 1996: Use these features for
optimization of pathway structure
Marin-Sanguino, Torres, Polisetty, Gatzke, Voit, …:
Extension to GMA models via 
iterative methods, branch-and-reduce methods,
geometric programming
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Citric acid yield:
Optimization prescribes 
enzyme activity levels 
that lead to maximal 
citric acid production 
while satisfying 
constraints on 
metabolites and fluxes.
Maximal increase:
~ 12 fold
Example
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Citric acid system contains ~ 20 accessible enzymes / genes
Optimize by allowing changes in all enzymes:
Yield increased ~ 12 fold
Q: If only a single enzyme may be changed, which one should it 
be? How much could yield be increased?
Notable Results
A: No matter which enzyme is changed, yield does not really
increase!
Q: Change 2, 3, … enzymes. Yield improvement?
A: 2: none; 3: none, 4-6: almost none; 7 needed for ~3 fold yield!
Interpretation: Standard techniques have found the easy solutions!
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‘The Other Optimization’: 
Parameter Estimation from 
Time Series Data
o According to computer scientists:  trivial, solved.
o Many methods
o Most work sometimes
o None works always
o Estimation remains to be a challenging topic!
o Example:  Kikuchi et al. 2003
o Over 100 papers on BST estimation since 2000
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Problems with Traditional Methods
Time to (global) convergence
Problems with collinear and or noisy data
Problems with models permitting redundancies
Problems with compensation of error among terms
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Problems with Traditional Methods:
Extrapolation
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X2 
X1 X0 
X3 
Generic model in GMA form
Bad parameters, but good fits
because of error compensation
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Problem with the “misestimated”
system during extrapolation
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b
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Dynamic Flux Estimation (DFE)
Inspired by Stoichiometric and Flux Balance Analysis
Extended to dynamic time courses
Study flux balance at each time point
Change in variable @ t = all influxes @ t – all effluxes @ t
Linear system; solve as far as possible
Result: values of each flux @ all t
Represent fluxes with appropriate models
36
Dynamic Flux Estimation (DFE)
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Test Bed: Regulation of Glycolysis in
Lactococcus lactis
www.hhmi.org/bulletin/winter2005/images/bacteria5.jpg
Bacterium involved in dairy, wine, bread, pickle production.
Relatively simple organization.
Here: study regulation of glycolysis.
Bacteria found in yogurt and cheese:
Lactococcus lactis (top),
Lactobacillus bulgaricus (blue), 
Streptococcus thermophilus (orange), 
Bifidobacterium spec (magenta). 
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Goals of Modeling
• Understand pathway; design, operation
• Allow extrapolation to new situations
• Allow prediction for manipulation
• Maximize yield of main product
• Optimize yield of secondary products
• Eventually develop a cell-wide model 
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Experimental Time Series Data
E.O. Voit, J.S. Almeida, S. Marino, R. Lall, G. Goel, A.R. Neves, and H. Santos:  IEE Proc. Systems Biol. 2006
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Lactococcus Data
Had modeled (fitted) these data before
First, difficult to find any solutions
Combination of methods led to good fit
Later, many distinctly different solutions
Question: Is any of these solutions optimal?
Question: Is the BST model appropriate?
Problems with extrapolation
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Dynamic Flux Estimation (DFE)
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DFE Rather Tolerant to Noise
43
DFE Spots “Wrong” Assumptions
44
Open Problems
Technical Issues:
Convergence to slow and not always global
Smoothing and Mass Conservation:
Noise in the data leads to loss or gain of mass
Underdetermined Flux Systems:
Linear system of flux often not of full rank
Augment DFE with other methods 
(e.g., regression or bottom-up estimation)
Characterization of Redundancies:
Data collinear or non-informative (pooling?)
Model allows transformation groups (Lie analysis?)
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Summary of Technical Talk
Biology has become too complicated not to use math
At the center of computational systems biology is a model
Nature does not provide guidelines for model design
Infinite choices; canonical models provide good default
Advantages of canonical models
Interpretation of parameters and other features
Computations associated with steady state
Optimization facilitated by model structure
(yield, parameters)
46
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IBSI:  An Overview
www.ibsi.gatech.edu
48
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History
Task Force 2004: Study Feasibility of an Entity like “The Institute 
for Computational and Systems Biology at Georgia Tech”
(Mark Borodovsky, Steve Harvey, John McDonald, Larry McIntire, 
Konstantin Mischaikow, Francois Sainfort, Anderson Smith, 
Eberhard Voit, Loren Williams)
Planning Committee 2005: What should such an entity look like? 
(Steve Harvey, Richard Lipton, Eberhard Voit)
Implementation Committee 2006: Hammer out the specifics
(Richard Fujimoto, Jeff Skolnick, Eberhard Voit)
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Phase 1 Activities
? Send surveys to faculty for input 
? Had several meetings
? Talked with key individuals
? Explored existing strengths
? Identified areas of need
? Explored models for integration and leadership
? Summarized thoughts in preliminary vision statement
? Discussed vision statement with key individuals
? Discussed implementation ideas with Deans, Science Chairs
? Initiated chalk-talk series (open to all interested parties)
? Submitted white paper to Deans (April 2006)
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Vision
This vision will require and be accomplished by:
? institution-wide participation and support
? leveraging existing strengths in biology, engineering,
computation, the natural sciences and mathematics
? creation of a physical (not only virtual) institute 
supporting systems research in biology
? strategic hiring in relevant areas
Georgia Tech will be a nationally and
internationally recognized, leading institution for 
research and study of integrative biological systems. 
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Goals
1.  Create a nationally and internationally recognized research 
environment dedicated to the investigation of integrative 
biological systems. 
2.  Leverage and consolidate existing biological, analytical, 
computational and engineering strengths at Georgia Tech
to form a synergistic, multidisciplinary task force for the 
analysis and manipulation of complex biomedical phenomena. 
3.  Develop graduate programs for the study of integrative 
biological systems.
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Rationale:  Why?  Why Now?
Motive: Molecular biology needs and facilitates systems-level 
reconstructionist approaches complementing 
traditional reductionist research.
Opportunity: Biology, engineering and computer science have
developed technologies and methods with unprecedented
potential, including:
? high-throughput genome, proteome, metabolic analysis
? data mining
? large scale simulation
? optimization techniques
? pattern recognition
? visualization
? in vivo sensing and imaging
? miniaturization, nanotechnology
? microfluidics, labs on chips
? synthetic biology
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Approaches within Biology
Data Collection: Observe, measure, create data:
hypothesis driven (e.g., enzyme kinetics)
high-density (e.g., microarrays)
From observation to quantitative data
Bioinformatics: Organize high-throughput data
“Data mining”
Extract patterns
From quantitative data to information
Biological Systems Analysis:
Make sense of data and patterns
Integrate information into predictive models
From information to understanding
Synthetic Biology: Reconstruct biology from bottom up
From understanding to innovation
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From observation to quantitative data
From quantitative data to information
From information to understanding
From understanding to innovation
Integrative Systems Biology
 
56
Question of “Value Added” Important:
What’s in it for GT?
What’s in it for each stakeholder?
Prospect of solving grand-challenge problems in
biology and medicine 
Solutions require complex, flexible teams 
of multi- and interdisciplinary scientists.  
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Multi-level assessments
Development of molecular inventories
Development of enabling technologies
for systemic approaches
Understand        manipulate       engineer systems 
create synthetic pathway systems
Guiding Themes: 
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Development of normal cells 
toward cancer
Health related microbial systems 
in the environment
High-performance computing 
in biology and medicine
Begin with Three Streams: 
 
59
Molecular Inventories 
Genomics
Proteomics
Modeling & Simulation 
Mathematical Analysis
HPC
Devices 
Sensing & Probing
Miniaturization
Multi-Level
Assessments
of 
Carcinogenesis
Multi-Level
Assessments
of Health-Related 
Environmental Systems
Initial Themes within  IBSI
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Implementation has Begun!
Personnel:
Executive Committee Named (Voit, Skolnick, Fujimoto)
Advisory Board Named (high-ranking GT faculty)
Rotating Directorship (Voit: 2008-2009; Skolnick 2010-2011)
Recruitment and Hiring:  Through Schools; but other entities 
part of recruitment process
Invitation to suggest potential senior hires to provost
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Implementation has Begun!
Research:
Funds for seed projects (at least two units to be involved)
Funds for shared graduate students (at least two faculty 
from different units to be involved)
Funds for distinguished seminar series
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Implementation has Begun!
Space:
New BioSystems Building
Building is top priority in GT’s capital campaign and planning
Swing space being negotiated
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Implementation has Begun!
Activities:
Chalk-talk series
Entered capital campaign as line item
Committees formed:
Advisory Board
Shared graduate students
Conference organizing committee
Website: www.ibsi.gatech.edu
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Implementation has Begun!
Events:
Brainstorming Workshop at Chateau Élan (October 16-17, 2006)
Poster Workshop (March 14, 2007) (featuring, e.g., Hang Lu)
Announcement Celebration: February 1, 2008
International Launch Conference: October 18-21, 2008
Roster of high-powered speakers
~ 150 attendees
Poster session
Venue:  Georgian Terrace Hotel
Distinguished Seminar Series
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Implementation has Begun!
Work in Progress
Develop graduate and postdoc programs
Training grants
Planning for IBSI building
Develop strategic partnerships
Emory, UGA, ISB, …
Industry
Eminent Visiting Scholar program (partially GRA funded)
Work toward self-sustainability  
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Wish List
Funds for:
IBSI building
Named directorship, faculty chairs, early career professorships
Research development awards
Named postdoc and graduate student awards
Seed grant program
Visiting scholar program
Institutional membership program
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What’s Next?
? Feedback from you
? Execute implementation 
? Be successful
This is a great opportunity and there is a lot of buzz
… all the way from the President and Provost
… to individual faculty all across campus
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Together, let’s integrate the buzz!
 
www.ibsi.gatech.edu
